
Industry
Drug Manufacturers - Specialty & Generic
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Loading...
Open
10.14
Mkt cap
46B
Volume
7.9M
High
10.19
P/E Ratio
24.76
52-wk high
10.80
Low
10.13
Div yield
0.00
52-wk low
7.89

Portfolio Pulse from
March 05, 2025 | 11:00 am

Portfolio Pulse from
February 27, 2025 | 3:00 pm



Portfolio Pulse from
February 25, 2025 | 10:30 am

Portfolio Pulse from
January 29, 2025 | 11:45 am


Portfolio Pulse from
December 02, 2024 | 1:00 pm
Portfolio Pulse from Dylan Berman
October 21, 2024 | 5:54 pm
Portfolio Pulse from Vandana Singh
October 11, 2024 | 12:57 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.